Skip to main content
Premium Trial:

Request an Annual Quote

University of Pittsburgh to Test WaferGen's Real-Time PCR System, Oncology Assays

NEW YORK (GenomeWeb News) – WaferGen said today that the University of Pittsburgh Medical School has agreed to alpha-test its SmartChip Real-Time PCR System and several oncology gene panel assays for the system.
 
WaferGen said the SmartChip Real-Time PCR System is a whole-genome gene expression platform that “promises to deliver significant speed and cost advantages to researchers in the gene expression and genotyping markets.”
 
The company said the system can conduct 33,750 assays on a chip, as compared to 384 assays per plate for standard real-time PCR technologies.
 
Researchers at the University of Pittsburgh Medical School plan to use the system to identify biomarkers for chronic obstructive pulmonary disease and lung cancer.
 
WaferGen said it is developing additional assays for the system, including toxicology assays, and that it is also developing a higher-throughput version of the system that will allow users to conduct 100,000 assays on a chip.
 
This capability will allow users to use one chip to conduct whole-genome gene expression in triplicate, the company said.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.